Jimson W. D’Souza, MD

Clinical Development Director
GSK

Multi-faceted professional with over 10 years in industry / academic oncology drug development who successfully works in cross-functional setting to consistently deliver high-quality work, clinical development plans and strategic planning. My background includes adoptive cell therapy and antibody engineering. I specialize in TCR-T cell therapy in solid tumors and hematologic malignancies.

Poster(s):

• (P 114) PRIMARY ANALYSIS OF EFFICACY AND SAFETY OF LETETRESGENE AUTOLEUCEL (LETE-CEL) AS FIRST-LINE TREATMENT FOR UNRESECTABLE OR METASTATIC SYNOVIAL SARCOMA (SS); SUBSTUDY 1 OF IGNYTE-ESO